2025 Annual Report of Independent Director (Lu Huawai)
As an independent director of Suhao Hongye Futures Co., Ltd. (hereinafter referred to as "the Company"), I, Lu Huawai, have diligently fulfilled my duties during my term in 2025 in accordance with the Company Law of the People's Republic of China, the Securities Law of the People's Republic of China, the Self-Regulatory Guidelines for Listed Companies on the Shenzhen Stock Exchange No. 1 - Standard Operations for Main Board Listed Companies, the Management Measures for Independent Directors of Listed Companies, and the Company's Articles of Association and Independent Director Work System. I actively participated in relevant meetings and thoroughly reviewed the board's proposals, effectively maintaining the interests of the Company and its shareholders. Below is my report on the performance of my duties as an independent director during 2025:
1. Basic Information of the Independent Director
I am Lu Huawai, holding a Master's degree in Management Science, a practicing member of the Hong Kong Institute of Certified Public Accountants, and a member of the American Institute of Certified Public Accountants, with over 20 years of experience in auditing and consulting services. I have served as an independent non-executive director of Shandong Xinhua Pharmaceutical Co., Ltd., and I am currently the Chairman and Executive Director of Bangmeng Huijun Consulting Co., Ltd., an independent non-executive director of Chongqing Machinery and Electric Co., Ltd., and an independent non-executive director of Tianfu (Cayman) Holdings Co., Ltd. I have been an independent non-executive director of the Company since December 23, 2021. During the reporting period, my position met the independence requirements stipulated in Article 6 of the Management Measures for Independent Directors of Listed Companies, and there were no circumstances affecting my independence.
2. Annual Performance Overview of the Independent Director
(1) Attendance at Board and Shareholder Meetings
In 2025, I diligently performed my duties, attending the Company's board and shareholder meetings, where I carefully read and reviewed all proposals presented. The specific attendance details are as follows:
| Meeting Type | Required Attendance | Actual Attendance | On-site Attendance | Communication Attendance | Proxy Attendance | Absences |
|---|---|---|---|---|---|---|
| Board Meeting | 9 | 3 | 2 | 7 | 0 | 0 |
| Shareholder Meeting | 3 | 3 | 0 | 0 | 0 | 0 |
I voted in favor of all proposals submitted to the board after careful consideration, with no instances of opposition or abstention. I believe that the convening and holding of the board and shareholder meetings complied with legal procedures, and all major operational decisions and other significant matters followed the relevant processes, being legal and effective.
(2) Performance in Board Committees and Independent Director Meetings
In 2025, I served as the Chairman of the Audit Committee, a member of the Risk Management Committee, a member of the Strategic and ESG Committee, and a member of the Nomination Committee (from August 27, 2025). I actively fulfilled my responsibilities as a committee member, gaining insights into the Company's operations and financial status, and providing professional opinions that positively influenced the board's decision-making. The specific performance details in the board committees are as follows: